SMTL ID : 4oas.2 (2 other biounits)

co-crystal structure of MDM2 (17-111) in complex with compound 25

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

monomer

Ligands

1 x 2SW: [(3R,5R,6S)-1-[(2S)-1-(tert-butylsulfonyl)butan-2-yl]-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl]acetic acid(Non-covalent)

2SW.1: 12 residues within 4Å: Chain A: L.39, F.40, G.43, Q.44, I.46, M.47, Y.52, V.78, K.79, H.81, I.84, Y.85 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.39, A:F.40, A:I.46, A:Y.52, A:V.78, A:I.84 Salt bridges: A:K.79, A:H.81 pi-Stacking: A:H.81 Halogen bonds: A:H.81

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sun, D. et al., Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2-p53 Inhibitor in Clinical Development. J.Med.Chem. (2014)

Release Date

2014-02-19

Peptides

E3 ubiquitin-protein ligase Mdm2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

E3 ubiquitin-protein ligase Mdm2

Related Entries With Identical Sequence